Affiliation:
1. Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran 14911-15719, Iran
Abstract
Lung cancer demands innovative approaches for early detection and targeted treatment. In addressing this urgent need, exosomes play a pivotal role in revolutionizing both the early detection and targeted treatment of lung cancer. Their remarkable capacity to encapsulate a diverse range of biomolecules, traverse biological barriers, and be engineered with specific targeting molecules makes them highly promising for both diagnostic markers and precise drug delivery to cancer cells. Furthermore, an in-depth analysis of exosomal content and biogenesis offers crucial insights into the molecular profile of lung tumors. This knowledge holds significant potential for the development of targeted therapies and innovative diagnostic strategies for cancer. Despite notable progress in this field, challenges in standardization and cargo loading persist. Collaborative research efforts are imperative to maximize the potential of exosomes and advance the field of precision medicine for the benefit of lung cancer patients.
Reference168 articles.
1. Nano based-oncolytic viruses for cancer therapy;Akhoondi;Crit. Rev. Oncol./Hematol.,2023
2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021
3. Doroudian, M., Azhdari, M.H., Goodarzi, N., O’Sullivan, D., and Donnelly, S.C. (2021). Smart Nanotherapeutics and Lung Cancer. Pharmaceutics, 13.
4. Lung cancer: Epidemiology, etiology, and prevention;Tanoue;Clin. Chest Med.,2011
5. Smart Lipid-Based Nanoparticles in Lung Cancer Treatment: Current Status and Future Directions;Shahrivar;Adv. Ther.,2023
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献